Why Measure Lactate Levels in Sepsis
Lactate levels should be measured in sepsis because elevated lactate (≥2 mmol/L) identifies patients at significantly higher risk of death and guides resuscitation efforts, serving as a critical marker of tissue hypoperfusion and metabolic stress that demands immediate intervention.
Primary Clinical Rationale
The Surviving Sepsis Campaign guidelines explicitly recommend measuring serum lactate as part of initial sepsis assessment and using elevated levels to guide resuscitation 1. Lactate measurement serves three essential functions: risk stratification, identification of cryptic shock, and monitoring response to treatment.
Risk Stratification and Mortality Prediction
The evidence demonstrates a clear dose-response relationship between lactate levels and mortality:
- Lactate ≥2 mmol/L: More than 10% of patients experience prolonged ICU stay or in-hospital death 2
- Lactate ≥4 mmol/L with hypotension: 44.5% mortality compared to 29% in patients without these criteria 3
- Each integer increase in lactate significantly increases odds of adverse outcomes, with adjusted ORs ranging from 2.65 to 3.89 for levels ≥1-4 mmol/L 2
The guidelines specifically recommend using lactate >4 mmol/L as a threshold for initiating aggressive quantitative resuscitation 1, 3.
Identifying Occult Hypoperfusion
A critical pitfall in sepsis management is missing patients with tissue hypoperfusion who appear hemodynamically stable. Lactate elevation can occur even without hypotension, identifying patients with "cryptic shock" who require intervention despite normal blood pressure 3. The 2016 guidelines shifted away from requiring hypotension to define sepsis-induced hypoperfusion, recognizing that lactate ≥4 mmol/L alone qualifies patients for early resuscitation protocols 1.
Guiding Resuscitation
The guidelines suggest "guiding resuscitation to normalize lactate in patients with elevated lactate levels as a marker of tissue hypoperfusion" (weak recommendation, low quality of evidence) 1. While this is a conditional recommendation, serial lactate measurements help define the patient's trajectory and should prompt therapeutic reassessment if levels remain stable or increase 4.
Important Caveats
Interpretation Beyond Hypoperfusion
A paradigm shift has occurred in understanding lactate biology. Hyperlactatemia in sepsis does not exclusively indicate tissue hypoxia—it can result from:
- Metabolic adaptation to stress (stress-induced aerobic glycolysis)
- Mitochondrial dysfunction
- Impaired lactate clearance
- Adrenergic stimulation 5
Hyperlactatemia should not be treated as a problem itself, but as a warning signal of altered cellular function requiring investigation and intervention 4.
Timing Limitations
Lactate concentrations change too slowly to guide minute-to-minute resuscitation decisions 4. They are best used for:
- Initial risk assessment at presentation
- Evaluating overall response to therapy over hours
- Triggering protocol activation rather than real-time fluid titration
Measurement Considerations
Recent evidence shows capillary lactate can be a reliable alternative to serum lactate, offering rapid point-of-care assessment with good predictive accuracy for short-term mortality 6. The optimal cut-off for capillary lactate appears higher (16.8 mmol/L for 48-hour mortality) than serum values.
Practical Implementation
All patients with suspected sepsis should have lactate measured within the first 3-6 hours 1. The screening algorithm should incorporate:
- Initial lactate at presentation for all suspected sepsis cases
- Repeat lactate within 6 hours if initial level ≥4 mmol/L (though compliance with serial measurement remains suboptimal at ~69%) 7
- Lower threshold (≥2 mmol/L) for triggering enhanced monitoring and specific interventions 2
High-Risk Gaps in Practice
Despite increasing lactate testing rates (from 11% in 2003 to 48% in 2013), significant measurement failures persist 7. Hospital-onset sepsis and patients on non-medical services are at highest risk of missed lactate measurements (adjusted OR 7.56 and 2.08 respectively) 7—these populations warrant targeted quality improvement efforts.
Integration with Clinical Assessment
Lactate should be interpreted alongside other markers of perfusion and organ dysfunction. The combination of qSOFA with lactate (qSOFA-lactate score) modestly improves risk stratification and can support nurse-led early identification of high-risk patients 8. This integrated approach facilitates timely care escalation without adding bedside complexity.
The 2025 German S3 guidelines and 2026 pediatric Surviving Sepsis Campaign guidelines continue to emphasize lactate measurement as fundamental to sepsis management, reinforcing its role in early individualized, evidence-based treatment 9, 10.